Dr. Baker is Scientific Founder and Chief Scientific Research Officer of BioCurity Pharmaceuticals. She has conducted cancer research for over 20 years and published more than 45 peer-reviewed manuscripts and book chapters. The proprietary technology supporting BioCurity’s mission to prevent side effects of radiation therapy was preclinically developed and tested by Dr. Baker and her research and physician-scientist colleagues at an MD Anderson Cancer Center. She received her BS in Chemistry and a Ph.D. in Biochemistry/Molecular Biology. She completed her postdoc at UT MD Anderson Cancer Center and conducted research as an Instructor of Surgery at Boston Children's Hospital & Harvard Medical School. She was an Assistant Professor at UT MD Anderson Cancer Center prior to serving as Director of the Cancer Research Institute at MD Anderson Cancer Center Orlando (formerly affiliated with Orlando Health). She has been a guest speaker at multiple events including the American Cancer Society.